LONG MINI-FUTURE - SARTORIUS VZ Share Price

Certificat

DE000VE2MQJ6

Delayed Deutsche Boerse AG 01:42:01 24/05/2024 pm IST
9.36 EUR -8.24% Intraday chart for LONG MINI-FUTURE - SARTORIUS VZ
Current month-18.14%
1 month-24.05%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24/24/24 9.36 -8.24%
23/24/23 10.2 -4.32%
22/24/22 10.66 -4.14%
21/24/21 11.12 +0.45%
20/24/20 11.07 +0.64%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 01:42 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying SARTORIUS AG
IssuerLogo Issuer Vontobel Vontobel
WKN VE2MQJ
ISINDE000VE2MQJ6
Date issued 04/10/2019
Strike 158.9
Maturity Unlimited
Parity 10 : 1
Emission price 3.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 48.69
Lowest since issue 2.45
Spread 0.02
Spread %0.21%

Company Profile

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Sector
-
More about the company

Ratings for Sartorius AG

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Sartorius AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
262.2 EUR
Average target price
325.8 EUR
Spread / Average Target
+24.26%
Consensus